HUB Investment Partners’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
HUB Investment Partners's BIIB Position: Q2 2026 in Review
HUB Investment Partners increased its Biogen (BIIB) stake by 3% in Q2 2026, buying an estimated $9.56K and bringing the position to 1,735 shares worth $375K. The position accounts for 0.01% of the portfolio, ranked #879.
HUB Investment Partners first reported a position in BIIB in Q4 2023 and has held it in 3 quarters since. 1,038 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- HUB Investment Partners held 1,735 shares of Biogen worth $375K as of Q2 2026.
- HUB Investment Partners bought 50 Biogen shares in Q2 2026, an estimated $9.56K.
- Biogen made up 0.01% of HUB Investment Partners's portfolio in Q2 2026, its #879 holding.
- HUB Investment Partners first reported a position in Biogen in Q4 2023 and has held it in 3 quarters since.
- 1,038 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on HUB Investment Partners's 13F filing for Q2 2026, filed 31 Jul 2026.